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AbstrACt
Introduction India has high prevalence of hypertension 
but low awareness, treatment and control rate. A cluster 
randomised trial entitled ‘m-Power Heart Project’ is 
being implemented to test the effectiveness of a nurse 
care coordinator (NCC) led complex intervention to 
address uncontrolled hypertension in the community 
health centres (CHCs). The trial’s process evaluation will 
assess the fidelity and quality of implementation, clarify 
the causal mechanisms and identify the contextual 
factors associated with variation in the outcomes. The 
trial will use a theory-based mixed-methods process 
evaluation, guided by the Consolidated Framework for 
Implementation Research.
Methods and analysis The process evaluation will 
be conducted in the CHCs of Visakhapatnam (southern 
India). The key stakeholders involved in the intervention 
development and implementation will be included as 
participants. In-depth interviews will be conducted 
with intervention developers, doctors, NCCs and health 
department officials and focus groups with patients and 
their caregivers. NCC training will be evaluated using 
Kirkpatrick’s model for training evaluation. Key process 
evaluation indicators (number of patients recruited and 
retained; concordance between the treatment plans 
generated by the electronic decision support system 
and treatment prescribed by the doctor and so on) will 
be assessed. Fidelity will be assessed using Borrelli et 
al’s framework. Qualitative data will be analysed using 
the template analysis technique. Quantitative data will 
be summarised as medians (IQR), means (SD) and 
proportions as appropriate. Mixed-methods analysis will be 
conducted to assess if the variation in the mean reduction 
of systolic blood pressure between the intervention 
CHCs is influenced by patient satisfaction, training 
outcome, attitude of doctors, patients and NCCs about the 
intervention, process indicators etc.
Ethics and dissemination Ethical approval for this study 
was obtained from the ethics committees at Public Health 
Foundation of India and Deakin University. Findings will be 
disseminated via peer-reviewed publications, national and 
international conference presentations.
trial registration number NCT03164317; Pre-results.
IntroduCtIon
Non-communicable diseases account for over 
60% of all deaths in India with cardiovascular 
disease being the leading cause.1 2 Among 
Indians, cardiovascular disease occurs a 
decade earlier, is more severe and is associ-
ated with a higher rate of mortality compared 
with their western counterparts.3 High 
systolic blood pressure (≥140 mm Hg) is the 
leading metabolic risk factor for cardiovas-
cular disease in India.4 The reported preva-
lence of hypertension in India is 25%.5 This 
high prevalence is compounded by low levels 
of awareness, treatment, control and subop-
timal self-management.6 
 m-Power Heart Project
The ‘m-Power Heart Project’ (here-
after referred to as m-Power) is a cluster 
randomised controlled trial (RCT) to deter-
mine the effectiveness of a nurse care coor-
dinator (NCC) led, mobile health (mHealth) 
strengths and limitations of this study
 ► Theory-based process evaluation, using an ev-
idence-based framework designed to evaluate 
healthcare innovations.
 ► The process evaluation is comprehensive, that is, it 
involves the intervention developers, implementers 
(the nurse care coordinators [NCCs]), the end users 
(doctors and patients) and health system actors.
 ► Process evaluation is being conducted alongside the 
intervention implementation thus giving information 
about the early implementation phase when chal-
lenges often occur.
 ► Recruitment of NCCs as key informants may intro-
duce response bias which is planned to be mini-
mised by reassuring the NCCs that the information 
they provide is only going to strengthen the imple-
mentation and has no effect on their employment.
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enabled intervention to decrease blood pressure among 
patients diagnosed with uncontrolled hypertension 
(blood pressure ≥160/90 mm Hg) visiting the community 
health centres (CHCs) in India. Full details of the trial are 
published elsewhere7; a brief summary of the trial meth-
odology is outlined below. Figure 1 presents the m-Pow-
er’s logic model.
The m-Power intervention has three main compo-
nents—an electronic decision support system (EDSS), 
short messaging service (SMS) and trained NCCs. The 
EDSS is a hypertension treatment algorithm incorpo-
rating national and international guidelines on hyper-
tension management8–10 and designed as an android 
application. The EDSS considers a patient’s age, blood 
pressure, medication use (type, dose and frequency) 
and co-morbid conditions influencing treatment choices 
(diabetes, asthma and so on), to generate a suitable treat-
ment plan, which the doctor can use to prescribe treat-
ment. The NCC co-manages the care of hypertensive 
patients with the doctor. A SMS programme provides 
information on high blood pressure to patients (risk 
factors, symptoms, complications, need for regular 
follow-up and adherence to recommended medications) 
and reminders for subsequent CHC visits. The primary 
outcome is the difference in the mean systolic blood 
pressure between the intervention and usual care arms at 
12 months. The study is designed to detect a 6.5 mm Hg 
systolic blood pressure difference with a power of 80%. 
Randomisation is at the level of the CHC, allocated at a 
1:1 ratio. Each of the 12 participating CHCs will recruit 
156 participants to achieve the total sample size of 1872.
Process evaluation
RCTs answer the question ‘Does the intervention work?’ 
whereas process evaluation of RCTs help to the ‘assess 
fidelity and quality of implementation, clarify the 
causal mechanisms and identify the contextual factors 
associated with variation in the outcome/s’.11 If a trial 
produces a null effect, process evaluation can differen-
tiate intervention failure from implementation failure. 
In a multi-centre trial, a process evaluation is necessary 
to understand if the intervention was implemented and 
received similarly across all sites.12 Context plays a crucial 
role in either the success or failure of an intervention. 
Process evaluation aids in the understanding of contex-
tual factors associated with intervention and imple-
mentation effectiveness, which can influence potential 
replication in different settings as well as scale up. Process 
evaluation often involves ad hoc selection of factors that 
may be important for understanding a trial’s implementa-
tion.13 Although this approach is better than the absence 
of any evaluation, a theory-informed process evaluation 
is better placed to understand the full determinants of 
outcomes. As such, theory-informed process evaluation 
findings may be more generalisable to similar problems 
in similar contexts among similar groups.13
We propose to conduct process evaluation of m-Power, 
guided by the Consolidated Framework for Implemen-
tation Research (CFIR)14 to understand 'what works, 
where, why and under what context?' CFIR is a system-
atic approach to identify factors that influence interven-
tion implementation and effectiveness. The framework 
consists of five domains (intervention characteristics, 
Figure 1 The logic model of the m-Power Heart Project. CHC, community health centre; DSS, decision support system; 
ICMR, Indian Council of Medical Research; NCC, nurse care coordinator; SMS, short messaging service.
3Srinivasapura Venkateshmurthy N, et al. BMJ Open 2019;9:e027841. doi:10.1136/bmjopen-2018-027841
Open access
outer setting, inner setting, characteristics of individuals 
and  process).14 The CFIR can be used to understand why 
implementation may or may not succeed, and identify 
potential barriers and facilitators to implementation.15 We 
seek answers to the questions below: (1) Who delivers the 
m-Power intervention and how often? (2) To what extent 
is m-Power intervention being implemented as planned? 
(3) How is m-Power intervention received by the target 
patient group and the CHC staff (doctors, nurses)? (4) 
What are the barriers to m-Power intervention delivery? 
and (5) Will any changes be made to the intervention 
implementation and what are they?
The objectives of the process evaluation are to:
1. Understand the intervention characteristics from 
the perspectives of different stakeholders—interven-
tion developers, NCCs, doctors, patients and their 
caregivers.
2. Describe and understand the context under which the 
intervention is being implemented.
3. Assess the fidelity of implementation.
MEtHods And AnAlysIs
A mixed-methods process evaluation of m-Power will be 
carried out using a concurrent triangulation design. The 
purpose of the mixed-methods is to corroborate the effec-
tiveness results (convergence) and to gain insights about 
the intervention, implementation and context, which can 
offset the inherent limitations, experienced using the 
quantitative or qualitative methods alone.
study setting
The m-Power Heart Project will be implemented in 
Visakhapatnam, the fourth largest district in the southern 
Indian state of Andhra Pradesh with a population of 
~4 200 000 people. Visakhapatnam has three distinct 
geographical areas—urban, rural and tribal. There are 
13 CHCs in Visakhapatnam. Within each CHC, three to 
eight doctors are posted and, on any given day between 
two to eight doctors are available for patient care. Outpa-
tient clinics run from 09:00 to 13:00 6 days a week with 
only emergency services provided outside those hours. 
A comprehensive diabetes and hypertension preven-
tion and management programme entitled UDAY16 is 
currently being implemented in one of the CHC and so it 
was excluded from m-Power.
theoretical approach
The CFIR was chosen to evaluate implementation of the 
m-Power Heart Project, as it is a complex intervention 
being implemented in a healthcare setting. The CFIR 
provides a degree of flexibility wherein researchers can 
select the constructs that are the most relevant to the 
study setting and use these to assess context, implemen-
tation and explain the study findings.14 Given that this 
process evaluation will not be measuring individual-level 
behaviour change, the CFIR domain ‘characteristics of 
individuals’ will not be assessed. Figure 2 presents the 
process evaluation constructs and their relation to four 
CFIR domains included in this study.
study participants
Participants included in this study represent key stake-
holders involved in the m-Power intervention devel-
opment and implementation. Participants include the 
m-Power cluster RCT investigators (intervention devel-
opers), NCCs (intervention implementers), doctors 
working in the CHCs (intervention users), patients with 
hypertension visiting the CHCs and their caregivers 
(intervention recipients) and health department officials 
(policy actors). We aim to recruit all 4 m-Power investiga-
tors (1 principal and 3 co-investigators); 2 doctors from 
each intervention CHC; all 6 NCCs (1 from each inter-
vention CHC); 8–12 patients, and their caregivers (within 
each intervention CHC); 1 state and 1 district programme 
officer of the National Programme for Prevention and 
Control of Cancer, Diabetes, Cardiovascular Disease and 
Stroke (NPCDCS) and 1 District Coordinator of Hospital 
Services (in-charge of all CHCs in Visakhapatnam 
district).
The m-Power investigators will be informed of the 
process evaluation and invited to take part in an interview 
via email from an investigator on the process evaluation 
study (SM). The recruitment email will contain a partic-
ipant information sheet and consent form. On consent, 
the first author (NSV) will contact the investigators via 
email and arrange an interview (either via telephone or 
in-person) at a time convenient for the investigator. The 
NCCs, doctors, patients together with their caregivers and 
health system officials will be recruited by the research 
assistant employed under the m-Power. The research assis-
tant will meet participants in-person, inform them about 
the process evaluation and provide individual participant 
information sheets and consent forms. We expect some 
patients will be illiterate or inadequately literate, and 
Figure 2 Select process evaluation components in relation 
to the Consolidated Framework for Implementation Research 
domains. CHC, community health centre; NCC, nurse care 
coordinator.
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for them the information sheet and consent form will 
be read aloud. If the participants consent to participate, 
then the research assistant will schedule the interview at 
a time convenient for the participant, either in the CHC 
(NCC, doctors and patients with their caregivers) or in 
the office of the health official.
data collection
Qualitative data will contribute to understanding the 
context, characteristics of the intervention from the 
perspective of different stakeholders and the challenges 
of implementation. Quantitative data will be used to 
assess the key process evaluation indicators. Data collec-
tion procedures are summarised in tables 1 and 2.
In-depth interviews
In-depth interviews will be conducted with the m-Power 
intervention developers, doctors, NCCs and health 
department officials by the first author (NSV). All inter-
views will be conducted in English with the exception 
of the interview with NCCs, who will be interviewed in 
the local language Telugu (spoken by all NCCs). After 
informing the participants about the study objectives 
and procedure, a series of open-ended questions will be 
asked to elicit opinions on the intervention development, 
intervention implementation challenges, facilitating 
and inhibiting factors, factors crucial for implementa-
tion, intervention effectiveness and potential scale up. 
Questions will capture participants’ understanding and 
perceptions of the intervention, context and process of 
implementation.
Focus group discussions
Two sets of focus groups will be conducted in each inter-
vention CHC—(a) among patients with hypertension and 
(b) among patients with hypertension together with their 
caregivers. A total of 24 focus groups will be conducted by 
the first author, with each focus group expected to last up 
to 1.5 hours. Each focus group will consist of 8–12 partici-
pants who will be purposively sampled to ensure adequate 
representation from different groups. Focus groups will 
elicit participant’s experience of receiving the interven-
tion, barriers and facilitators in accessing CHC services, 
Table 1 Summary of in-depth interviews and focus groups
Data collection 
method Participants Place of data collection and mode
In-depth interviews Intervention developers (n=4) In-person or via teleconference; investigators 
office in Gurgaon, India
Doctors (n=2) In-person; in the CHCs where they are working
NCCs (n=6) In-person; in the CHCs where they are working
District (n=1) and state (n=1) NPCDCS programme 
officers and District Coordinator of Hospital 
Services (n=1)
In-person; in their respective offices
Focus groups Patients (n=12) In the CHC which they visit for treatment
Patients  together with caregivers (n= 12) 
CHC, community health centre; NCC, nurse care coordinator; NPCDCS, National Programme for Prevention and Control of Cancer, Diabetes, 
Cardiovascular Disease and Stroke.
Table 2 Summary of quantitative data collection
Data type Source Mode of collection
Process indicators
 ► Number of patients recruited and retained 
throughout the intervention.
 ► Number of visits by the patients.
 ► Number of treatment plans generated.
 ► Concordance between the doctor and 
EDSS generated treatment plan.
 ► Number of SMSs sent to patients.
 ► Number of SMSs bounced back.
Stored in the m-Power central server Captured automatically by the EDSS and 
transferred to central server
Implementation fidelity
Training. OSCE
Delivery. Observation assessment Checklist, NCC activity diaries 
Receipt. Exit interview with patients Questionnaire
EDSS, electronic decision support system; NCC, nurse care coordinator; OSCE, objective structured clinical examination; SMS, short 
messaging service.
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availability of essential drugs and issues around adopting 
healthy lifestyle behaviours to reduce blood pressure and 
so on. Discussions will be moderated by a facilitator (first 
author) with a note taker (research assistant) present to 
ensure that all topics are covered and any relevant inter-
actions are recorded. All interviews and focus groups will 
be audio recorded for later transcription. To accommo-
date the local language needs and health literacy of the 
patient group, focus groups will be conducted in Telugu 
and later transcribed into English.
nCC training evaluation
The NCCs will be trained to deliver the intervention by 
the research assistant. The induction training programme 
consists of learning standardised processes for measuring 
blood pressure, weight, height and reviewing the lab 
reports of the patients with hypertension. NCCs will also 
be trained to use the EDSS and generate the treatment 
plan that will be shared with the doctors. The training 
programme takes 132 hours, of which 12 hours are for 
the final assessment of competency. Training sessions 
include presentations, lectures, hands-on exercises using 
the EDSS, mock field visits and patient interactions. Kirk-
patrick’s model for training evaluation17 will be used to 
evaluate the NCCs training. Three of the four assess-
ment levels will be evaluated—reaction, learning and 
behaviour. The first two levels will be assessed by the 
training evaluation. The objective structured clinical 
examination (OSCE) assessment method will be used 
to assess learning. The third level (behaviour) will be 
assessed as a part of the implementation fidelity. The final 
level in the model (results) will not be assessed as this 
level includes parameters such as increased production, 
improved work quality and reduced turnover, which do 
not apply to the intervention.
Process evaluation indicators
The following five indicators will be assessed—(1) number 
of patients recruited and retained throughout the inter-
vention, (2) number of CHC visits by the patients, (3) 
number of treatment plans generated, (4) concordance 
between the treatment plans generated by the doctor 
and EDSS and (5) number of SMSes sent to patients and 
the number of SMSes that bounced back. The EDSS is 
designed to capture the information required to measure 
all five indicators. The information captured will be 
stored in a secure central server within the Public Health 
Foundation of India (PHFI) office in Gurgaon, India.
Fidelity of implementation
Consistent with Borrelli et al’s18 framework, fidelity will be 
assessed according to the following categories—design, 
training, delivery and receipt. Enactment (also included 
in Borrelli et al’s framework) is being excluded as it is 
beyond the scope of the current study. The category of 
training has been explained under the NCC training eval-
uation section. During the trial implementation, obser-
vations in the intervention CHCs will be carried out by 
the first author at least monthly, and at least fortnightly 
by the trained research assistant. The observation assess-
ment will last ~30 min with both assessors completing a 
structured checklist consisting of items to evaluate the 
workspace, use of logistics, interaction of the NCC with 
the patient, eliciting patient history, entering data into 
the EDSS, measuring blood pressure and generating a 
treatment plan. NCCs are required to maintain a daily 
activity diary. A minimum of one session is to be carried 
out per week by each NCC in their respective CHC. The 
number of counselling sessions conducted and number 
of patients attending each session will be extracted from 
the NCC activity diaries. Participant exit interviews after 
a counselling session with the NCC will assess receipt of 
the intervention. An interviewer administered question-
naire will be developed in English, translated into Telugu 
and back translated to English to check for consistency. 
The interview will be administered by the research assis-
tant in Telugu to gather information about the counsel-
ling session vis-à-vis quality, recall of the key messages and 
satisfaction levels. A total of 25 participants (5 each from 
5 different sessions spread over 6 months) from each 
of the intervention CHC will be selected randomly and 
interviewed, yielding a total of 90 interviews.
Analysis
The interview transcripts will be translated (from Telugu 
to English) and transcribed as soon as the interviews 
are completed to allow for changes in the interview and 
discussion guide, if required. Audio recordings will be 
transcribed and translated to English as soon as possible 
after interviews and focus groups. A single investigator 
(NSV) will perform all transcription and translation for 
consistency purposes. Data immersion, coding, category 
creation and thematic analysis will be undertaken by a 
single investigator (NSV) using the template analysis 
technique19 for the coding steps. This technique uses 
predefined codes, which may be amended, or new codes 
added based on the transcription data. Transcripts will 
be entered into NVivo V.11 for analysis. Ten transcripts 
will be independently analysed by a researcher based at 
PHFI but not associated with the m-Power, to establish 
inter-rater reliability. Discrepancies will be discussed with 
the study co-authors (KMN or HK) until consensus is 
reached that the coding is representative of the data.
The NCC training evaluation data from the OSCE will 
be summarised into medians (IQR) and the change in 
scores pre-training and post-training will be calculated. 
The checklist data will be summarised into means and a 
mean score will be calculated. The number of counsel-
ling sessions and the participation in each session will 
be enumerated and totalled. The proportion of study 
participants attending at least 80% of the sessions will be 
calculated. Means and proportions will be calculated for 
the data from the exit interviews. All data analysis will be 
carried out in Stata V.14.
For the mixed-methods analysis, apart from the qualita-
tive and quantitative data described above, we will use the 
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result of primary outcome of the trial for each interven-
tion CHC (mean change in the systolic blood pressure). 
We will look for convergence by analysing the qualitative 
and quantitative data to explore if the variation in the 
mean reduction of systolic blood pressure between the 
intervention CHCs is influenced by factors like patient 
satisfaction, session attendance, training outcome, atti-
tude of doctors, patients and NCCs about the interven-
tion, process indicators and so on (figure 3).
Patient and public involvement
The process evaluation is comprehensive as we plan to 
include all stakeholders. Patients and their caregivers are 
study participants. We will elicit information on receipt 
of intervention, challenges in implementing lifestyle 
changes to control blood pressure, barriers to access 
services at the CHC and so on. The patients will also be 
interviewed as a part of exit interview to assess the receipt 
and recall of key messages, satisfaction level with the 
NCC sessions and so on. The results of the study will be 
shared with the patients and their caregivers by providing 
a one-page summary in local language through the NCCs. 
In the manuscript, patients and their caregivers will be 
acknowledged for their contribution.
EtHICs And dIssEMInAtIon
Findings will be disseminated via peer-reviewed 
publications, national and international conference 
presentations.
ConClusIon
This study will be the first theory-based process eval-
uation of a hypertension management trial in India. 
Although studies have been conducted in India to 
test the efficacy of task shifting, EDSS and mHealth on 
blood pressure control in hypertension, either alone or 
in combination,20–22 none of them were assessed using 
a rigorous process evaluation. To tackle the burden of 
hypertension, innovative approaches are required and 
we believe that the m-Power Heart Project intervention 
is one such solution. Our process evaluation is guided 
by the use of an evidence-based framework designed to 
evaluate healthcare innovations, and it will be conducted 
alongside the intervention implementation thus giving 
information about the early implementation phase when 
challenges often occur. We do anticipate following chal-
lenges in conducting the evaluation—low literacy among 
some patients (and possibly their care givers), hierar-
chical culture and social desirability bias. Findings from 
this process evaluation will elucidate which contextual 
factors are associated with intervention effectiveness 
and the challenges to implementation within the public 
healthcare system of India. Findings will also inform 
the wider implementation of the intervention through 
the NPCDCS and the potential scale up in other states 
in India. If the trial findings are positive, the evaluation 
can provide evidence to embed the intervention into the 
aforesaid existing national programme to address hyper-
tension control strategies. If the trial findings are nega-
tive, then the evaluation will help understand whether it 
was an intervention or implementation failure.
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Figure 3 Schema of mixed-methods analysis 
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